Green Cross plans to take over a foreign pharmaceutical firm producing vaccines within this year, Meritz Securities reported on September 13.
“We are waiting for a good chance to increase its annual sales by 100 billion won with a timely M&A,” said a company official.
Green Cross, which ranked second in terms of revenue last year, announced last July that its first-half revenue jumped 72....
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.